Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Lifeward Ltd. | 50,000 | reported | 02 Aug 2022 | tx 28+243,244−326,130 |
| Baudax Bio, Inc. | 42,900 | reported | 15 Jun 2022 | tx 7+266,783 |
| Recro Pharma, Inc. | 0 | reported | 08 Apr 2024 | tx 46+3,800,597−2,400,618 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 08 Apr 2024 | OTHER | Recro Pharma, Inc. | 73,620 | 1.10 USD | |
| 08 Apr 2024 | TENDER | Recro Pharma, Inc. | 234,982 | 1.10 USD | |
| 08 Apr 2024 | OTHER | Recro Pharma, Inc. | 27,229 | — | deriv |
| 08 Apr 2024 | OTHER | Recro Pharma, Inc. | 118,182 | — | deriv |
| 28 Aug 2023 | PURCHASE | Recro Pharma, Inc. | 62,500 | 0.40 USD | first after silence |
| 17 May 2023 | GRANT_AWARD | Recro Pharma, Inc. | 73,620 | — | |
| 17 May 2023 | GRANT_AWARD | Recro Pharma, Inc. | 27,229 | 0.00 USD | deriv |
| 02 Aug 2022 | GRANT_AWARD | Lifeward Ltd. | 50,000 | 0.00 USD | |
| 15 Jun 2022 | GRANT_AWARD | Baudax Bio, Inc. | 39,473 | 0.00 USD | |
| 18 May 2022 | GRANT_AWARD | Recro Pharma, Inc. | 87,500 | — | |
| 18 May 2022 | GRANT_AWARD | Recro Pharma, Inc. | 118,182 | 0.00 USD | deriv |
| 15 Nov 2021 | SALE | Lifeward Ltd. | 4,129 | 1.53 USD | |
| 21 May 2021 | GRANT_AWARD | Lifeward Ltd. | 20,833 | 0.00 USD | |
| 20 Apr 2021 | GRANT_AWARD | Recro Pharma, Inc. | 26,923 | 0.00 USD | |
| 20 Apr 2021 | GRANT_AWARD | Recro Pharma, Inc. | 38,012 | 0.00 USD | deriv |
| 07 Apr 2021 | GRANT_AWARD | Baudax Bio, Inc. | 56,452 | 0.00 USD | |
| 07 Apr 2021 | GRANT_AWARD | Baudax Bio, Inc. | 83,333 | 0.00 USD | deriv |
| 02 Jul 2020 | GRANT_AWARD | Lifeward Ltd. | 10,948 | 0.00 USD | |
| 07 May 2020 | GRANT_AWARD | Recro Pharma, Inc. | 8,363 | 0.00 USD | |
| 07 May 2020 | GRANT_AWARD | Recro Pharma, Inc. | 12,405 | 0.00 USD | deriv |
| 06 May 2020 | GRANT_AWARD | Baudax Bio, Inc. | 22,951 | 0.00 USD | |
| 06 May 2020 | GRANT_AWARD | Baudax Bio, Inc. | 34,574 | 0.00 USD | deriv |
| 26 Mar 2020 | PURCHASE | Baudax Bio, Inc. | 10,000 | 2.29 USD | first after silence |
| 05 Dec 2019 | GRANT_AWARD | Recro Pharma, Inc. | 15,284 | 0.00 USD | |
| 05 Dec 2019 | GRANT_AWARD | Baudax Bio, Inc. | 20,000 | 0.00 USD |
2 purchases reported after at least 12 months of silence — most recent on 28 Aug 2023.